Compare Stocks

Enter up to five stock symbols separated by a comma or space (e.x BAC,WFC,JPM,LON:BARC).
 

 Check Cap1933 Industries21st NorthAbacus Health ProductsAbattis Bioceuticals
SymbolNASDAQ:CHEKN/AOTCMKTS:ULGXOTCMKTS:ABAHFOTCMKTS:ATTBF
Price Information
Current Price$2.02N/A$0.0044$5.3820$0.02
52 Week RangeBuyN/AN/AN/AN/A
Analyst Ratings
Consensus RecommendationBuyN/AN/AN/AN/A
Consensus Price Target$10.50N/AN/AN/AN/A
% Upside from Price Target419.80% upsideN/AN/AN/AN/A
Trade Information
Market Cap$3.23 millionN/AN/AN/AN/A
BetaN/AN/A4.18N/AN/A
Average VolumeN/AN/A3,8657,902606,738
Sales & Book Value
Annual RevenueN/AN/AN/AN/AN/A
Price / SalesN/AN/AN/AN/AN/A
CashflowN/AN/AN/AN/AN/A
Price / CashN/AN/AN/AN/AN/A
Book Value$8.12 per shareN/AN/AN/AN/A
Price / BookN/AN/AN/AN/AN/A
Profitability
Net Income$-10,590,000.00N/AN/AN/AN/A
EPS($2.61)N/AN/AN/AN/A
Trailing P/E RatioN/A0.000.000.000.00
Forward P/E RatioN/AN/A
P/E GrowthN/AN/AN/AN/AN/A
Net MarginsN/AN/AN/AN/AN/A
Return on Equity (ROE)-83.70%N/AN/AN/AN/A
Return on Assets (ROA)-72.16%N/AN/AN/AN/A
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity RatioN/AN/AN/AN/AN/A
Current Ratio6.84%N/AN/AN/AN/A
Quick Ratio6.84%N/AN/AN/AN/A
Ownership Information
Institutional Ownership PercentageN/AN/AN/AN/AN/A
Insider Ownership PercentageN/AN/A8.50%N/AN/A
Miscellaneous
Employees56706129N/A
Shares Outstanding1.60 millionN/AN/AN/AN/A
Next Earnings Date11/4/2019 (Estimated)N/AN/AN/AN/A
OptionableNot OptionableNot OptionableNot OptionableNot OptionableNot Optionable
 Check Cap1933 Industries21st NorthAbacus Health ProductsAbattis Bioceuticals

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel